Louisiana launches statewide immune health testing initiative
Jun 12, 2026
KEY TAKEAWAYS:
Louisiana and Phenomune launched a statewide initiative offering up to 250,000 free at-home immune health test kits.
Residents ages 13 and older can receive personalized immune insights through a simple taste-based assessment.
State officials say the program is the first of its
kind and aims to improve preventive healthcare and public health planning.
Healthcare providers statewide can integrate the testing program into patient care with support from Phenomune’s clinical outreach team.
The Louisiana Department of Health and biotechnology company Phenomune have launched a statewide initiative that will provide up to 250,000 free at-home test kits designed to give residents personalized insights into their immune health and susceptibility to respiratory illnesses.
Announced June 11, the program allows Louisiana residents ages 13 and older to request a no-cost test kit and complete a brief taste-based assessment from home, in a healthcare setting or through community organizations. Participants receive personalized results through the Phenomune mobile app within minutes, with information intended to help guide conversations with healthcare providers.
State officials said the initiative is the first of its kind in the nation and is intended to strengthen preventive healthcare while generating population-level data that could help inform future public health planning.
The test uses four taste strips placed on the tongue to assess an individual’s innate immune profile. According to Phenomune, the science is based on research linking certain taste receptors to respiratory health and the body’s natural immune defenses. No laboratory testing or biological samples are required.
Gov. Jeff Landry said the initiative supports a more preventive approach to healthcare while expanding access to health information, particularly in rural areas.
“Louisiana is taking a bold step to lead on preventive health by putting science-backed tools directly into the hands of our people,” Landry said. “This effort strengthens healthcare across our state — particularly in rural communities — while advancing more proactive, outcomes-driven approaches to care that align with Medicaid and broader federal priorities that can help reduce strain on the healthcare system.”
The state said participants’ results remain private and can be shared with healthcare providers at their discretion.
In addition to providing individuals with information about their immune health, officials said the program is designed to generate broader population-level insights that could help healthcare leaders better allocate resources, encourage earlier intervention and reduce avoidable emergency room visits.
Louisiana Surgeon General Dr. Evelyn Griffin said the initiative reflects a shift toward proactive healthcare.
“Louisiana has an opportunity to lead by rethinking how we approach prevention — shifting from reactive care to proactive, data-informed action,” Griffin said. “By equipping patients and providers with clinically grounded insights, this effort can support earlier intervention, strengthen decision-making and contribute to improved health outcomes across our state.”
Healthcare providers, hospitals, federally qualified health centers, nursing homes and community clinics can also participate by ordering kits for patients and incorporating the program into clinical care. Phenomune said its clinical outreach team will assist healthcare organizations with implementation.
Phenomune founder Dr. Henry P. Barham said the company developed the platform to make complex scientific research more accessible to consumers.
“At Phenomune, our focus is translating peer-reviewed science into practical tools that anyone can easily use,” Barham said. “This helps people better understand their own immune system so they can take a more proactive approach to their health — and, over time, build healthier communities.”
Barham, a Louisiana native and board-certified ear, nose and throat physician, has authored more than 150 peer-reviewed publications and leads multiple clinical trials each year. The company said its testing approach is supported by peer-reviewed research, including a study involving more than 2,000 participants published in the Journal of the American Medical Association. Additional research has appeared in journals including the American Journal of Rhinology Allergy, Viruses and the International Forum of Allergy Rhinology.
Residents can request test kits through Phenomune’s website, while healthcare providers can order kits for use in clinical settings.
...read more
read less